Who should not take HGH Fragment 176-191?
Documented caution flags for HGH Fragment 176-191 include active malignancy and pregnancy / nursing. This is not exhaustive, and absence from this list is not a safety clearance. Anyone pregnant, nursing, or managing a serious medical condition should only consider it under a doctor's care, and safety data for HGH Fragment 176-191 is limited.
Documented caution flags for HGH Fragment 176-191
- Active malignancy
- Pregnancy / nursing
Reported side effects to weigh
- Mild injection-site irritation
- Rare: headache
References
- The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice — Heffernan M, Summers RJ, Thorburn A, et al., Endocrinology, 2001
- Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone — Ng FM, Sun J, Sharma L, et al., Hormone Research, 2000
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on HGH Fragment 176-191
Full HGH Fragment 176-191 breakdownHGH Fragment 176-191 what it's used forHGH Fragment 176-191 side effectsHGH Fragment 176-191 how to take itHGH Fragment 176-191 mistakes to avoidHGH Fragment 176-191 half-lifeHGH Fragment 176-191 how long to workHGH Fragment 176-191 legal statusHGH Fragment 176-191 how it worksaod 9604 vs hgh frag 176 191Ask the AI Coach
Last updated 2026-06-15.